Diabetologia

Papers
(The H4-Index of Diabetologia is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Up Front756
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 2025493
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo222
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]206
60th EASD Annual Meeting of the European Association for the Study of Diabetes205
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection185
Methodological considerations for interpreting long-term statin use and diabetes incidence142
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification133
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study129
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq127
Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative127
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities110
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk100
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study100
58th EASD Annual Meeting of the European Association for the Study of Diabetes99
Ageing well with diabetes: the role of technology97
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study95
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]93
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin90
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes90
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory90
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people90
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes85
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study82
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care81
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation80
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes79
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)75
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes75
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials73
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy73
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study72
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells72
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy71
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap70
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial70
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes70
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk69
The role of automated insulin delivery technology in diabetes68
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry66
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data64
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial63
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations63
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study63
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open62
Up Front61
Daniel Porte Jr, 13 August 1931–13 May 202356
Mortality risk for kidney transplant candidates with diabetes: a population cohort study55
Pinpointing precision medicine for diabetes mellitus55
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals54
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women54
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis52
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications52
0.23625802993774